Six non-diabetes benefits of metformin shown in trials, and the TAME aging hypothesis
The post lists six effects of metformin reported in randomized trials of non-diabetics (long Covid, Covid outcomes, periodontal disease, muscle loss, knee osteoarthritis pain, oral pre-cancer lesions) and argues they share aging as a risk factor. It mentions a monkey study and the planned TAME trial testing whether metformin slows aging; most evidence is linked via Facebook shares.




